Assignee
CENTRO INMUNOLOGIA MOLECULAR
CU·10 granted patents·5 pending applications·1,340 citations·filing 1994–2014
Top patents by PatentIndex Score
15 records- 0195US5891996AHumanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic useCENTRO INMUNOLOGIA MOLECULAR·Filed 1995·Granted Apr 6, 1999·743 cites·8 claims
- 0293US6506883B2Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic useCENTRO INMUNOLOGIA MOLECULAR·Filed 1998·Granted Jan 14, 2003·283 cites·12 claims
- 0393US5712120AMethod for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing themCENTRO INMUNOLOGIA MOLECULAR·Filed 1995·Granted Jan 27, 1998·162 cites·4 claims
- 0475US5894018AVaccine composition comprising autologous epidermal growth factor or a fragment or a derivative thereof having anti-tumor activity and use thereof in the therapy of malignant diseasesCENTRO INMUNOLOGIA MOLECULAR·Filed 1996·Granted Apr 13, 1999·71 cites·15 claims
- 0571US7744871B2Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activityCENTRO INMUNOLOGIA MOLECULAR·Filed 2006·Granted Jun 29, 2010·3 cites·59 claims
- 0664US6149921AVaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatmentCENTRO INMUNOLOGIA MOLECULAR·Filed 1998·Granted Nov 21, 2000·35 cites·22 claims
- 0755US2006036082A1Method of obtaining cell lines in a protein-free medium and cell lines thus obtainedCENTRO INMUNOLOGIA MOLECULAR·Filed 2003·Application pending·0 cites
- 0851US5817513AAnti ganglioside monoclonal antibodiesCENTRO INMUNOLOGIA MOLECULAR·Filed 1994·Granted Oct 6, 1998·24 cites·19 claims
- 0950US2016024220A1Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritisCENTRO INMUNOLOGIA MOLECULAR·Filed 2014·Application pending·0 cites
- 1047US2006251654A1Method for treatment of malignant and infectious chronic diseasesCENTRO INMUNOLOGIA MOLECULAR·Filed 2006·Application pending·0 cites
- 1145US2016166667A1Divalent vaccine compositions and the use thereof for treating tumorsCENTRO INMUNOLOGIA MOLECULAR·Filed 2014·Application pending·0 cites
- 1244US6063379AAnti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodiesCENTRO INMUNOLOGIA MOLECULAR·Filed 1998·Granted May 16, 2000·11 cites·5 claims
- 1343US2010197011A1Method of obtaining cell lines in a protein-free medium and cell lines thus obtainedCENTRO INMUNOLOGIA MOLECULAR·Filed 2010·Application pending·0 cites
- 1438US5788985AVaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatmentCENTRO INMUNOLOGIA MOLECULAR·Filed 1994·Granted Aug 4, 1998·8 cites·18 claims
- 1526US6491914B1Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodiesCENTRO INMUNOLOGIA MOLECULAR·Filed 1999·Granted Dec 10, 2002·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when CENTRO INMUNOLOGIA MOLECULAR files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →